I don't see the point, atm we are sitting on what, maybe 10% of where ADI could be. Limited information will see the sp do absolutely nothing, and once again bring that groundhog back.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come